Chief Executive Officer @ (January 2024 - May 2025)
CEO at BioDuro-Sundia (an Advent International company) @ (December 2019 - July 2023)
Partner @ Asklepios Capital LLC (August 2006 - February 2022)
CEO @ Socorro Pharmaceuticals (February 2017 - April 2019)
Corporate Strategy Advisor @ Life Science Institute, Inc. (a subsidiary of Mitsubishi Chemical Holdings) (February 2015 - October 2016)
President and Board Director @ (January 2014 - October 2016)
Partner and Principal Consultant @ CoreFactor (January 2013 - September 2014)
Non-Executive Chairman @ PDS Biotechnology (January 2009 - January 2014)
Vice President and General Manager @ (July 2007 - January 2013)
Vice President and General Manager @ (August 2005 - July 2007)
VP R and D @ (September 2004 - August 2005)
Kent Payne Education
Brigham Young University
Ph.D. (Analytical Chemistry)
1985-1989
Kent Payne Skills
FDA
Pharmaceutical Industry
Biotechnology
Biopharmaceuticals
Technology Transfer
R&D
Commercialization
Strategy
GMP
Validation
Medical Devices
Life Sciences
Formulation
Drug Development
Clinical Trials
Product Development
Pharmaceutics
Strategic Leadership
Analytical Chemistry
Regulatory Submissions
Aseptic Processing
Business Development
Business Strategy
Change Control
Chemistry
Clinical Development
Continuous Process Improvement
Cross-functional Team Leadership
Drug Delivery
Drug Discovery
Laboratory
Leadership
Lean Manufacturing
Lifesciences
Management
Manufacturing
Marketing
Marketing Strategy
Mergers & Acquisitions
Operational Excellence
Product R&D
Quality System
Regulatory Affairs
Regulatory Requirements
Research and Development (R&D)
Sales
Sales Management
Start-ups
Strategic Planning
Team Building
Chromatography
CRO
HPLC
Angel Investing
Start Ups
GxP
Cleaning Validation
Management Consulting
Research and Development R&d
V&V
Cross Functional Team Leadership
Vaccines
Strategic Consulting
Lean Six Sigma
GLP
LIMS
Mergers and Acquisitions
CAPA
Sop
21 CFR Part 11
Research and Development
Kent Payne Summary
Kent Payne, based in United States, is currently a Managing Director at Wilmington PharmaTech Company LLC. Kent Payne brings experience from previous roles at Curewell Capital, Goodwin Biotechnology, Inc., Aliri and BioDuro-Sundia. Kent Payne holds a 1985 - 1989 Ph.D. in Analytical Chemistry @ Brigham Young University. With a robust skill set that includes FDA, Pharmaceutical Industry, Biotechnology, Biopharmaceuticals, Technology Transfer and more. Kent Payne has 5 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Kent Payne?
Find contact details for 700 million professionals.